Covid-19 man­u­fac­tur­ing roundup: As­traZeneca strug­gling to make planned vac­cine de­liv­er­ies to EU; J&J out­lines plans to pro­vide 100M dos­es of Covid vac­cine in US as Pfiz­er, Mod­er­na promise speed­i­er de­liv­ery

As J&J neared FDA ap­proval for its Covid-19 vac­cine in the US, with plans to start ship­ping dos­es quick­ly, No­vavax and As­traZeneca are hus­tling along …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.